Pharmacy compounder files antitrust lawsuit against Eli Lilly and Novo Nordisk
Strive Specialties sued Eli Lilly and Novo Nordisk, alleging anticompetitive practices restricting access to weight loss drugs.Summary
Strive Specialties, a compounding pharmacy, has filed an antitrust lawsuit against Eli Lilly and Novo Nordisk, accusing them of employing anticompetitive tactics to hinder its ability to serve patients seeking weight loss medications. The lawsuit alleges that the drugmakers entered into exclusive agreements with telehealth providers, preventing them from collaborating with compounding pharmacies. Additionally, Strive Specialties claims Lilly and Novo Nordisk interfered with their relationships with payment processors and social media platforms, and engaged in disparaging compounded medicines by falsely labeling them as illegal or unsafe. According to the lawsuit, these actions “unlawfully restricted competition and directly harmed patients in the U.S.,” forcing patients to pay higher prices and limiting access to personalized medications. The case was filed in a U.S. district court in Texas.
(Source：Stat)